Filter
196
Filtered Results: 196
Text search:
Müller,
O
Featured
Recommendations
25
New Publications
24
Language
Document type
No document type
83
Guidelines
53
Studies & Reports
41
Manuals
10
Strategic & Response Plan
4
Training Material
3
Situation Updates
2
Countries / Regions
Global
12
Russia
10
South Africa
8
Latin America and the Carribbean
6
Germany
4
Ukraine
4
Western and Central Europe
4
Eastern Europe
4
India
3
Indonesia
3
Middle East and North Africa
3
Eastern Europe and Central Asia
3
USA
2
Uganda
2
Philippines
2
South Sudan
2
Syria
2
Kenya
2
Rwanda
2
Mozambique
2
Argentina
2
Yemen
2
West and Central Africa
2
Congo, Democratic Republic of
1
Mali
1
Nepal
1
Zambia
1
Cambodia
1
Sudan
1
Benin
1
Brazil
1
Angola
1
Lesotho
1
East and Southern Africa
1
Paraguay
1
Africa
1
Venezuela
1
Vietnam
1
France
1
Spain
1
Authors & Publishers
Publication Years
Category
Countries
56
Clinical Guidelines
18
Pharmacy & Technologies
6
Women & Child Health
4
Public Health
2
Key Resources
2
Toolboxes
COVID-19
39
Mental Health
23
AMR
18
HIV
11
Planetary Health
10
TB
8
NTDs
8
Disability
7
Rapid Response
5
Caregiver
4
Pharmacy
4
Health Financing Toolbox
3
Ebola
2
Refugee
2
Global Health Education
2
NCDs
2
Cholera
1
Specific Hazards
1
The ECDC, the EFSA and the EMA have for the first time jointly explored associations between consumption of antimicrobials in humans and food-producing animals, and antimicrobial resistance in bacteria from humans and food-producing animals, using 2...
Unhealthy diets and excess body weight are leading risk factors for death and disability in the WHO European Region. Addressing malnutrition in all its forms is essential to ensure health and well-being for all and, consequently, sustainable development. It requires coherent and innovative actions c...
Epidemiology
Chagas disease (American trypanosomiasis) is caused by the protozoan parasite Trypanosoma cruzi, and transmitted to humans by infected triatomine bugs, and less commonly by transfusion, organ transplant, from mother to infant, and in r...
Bulletin of the World Health Organization, 2000, 78 (6)
The Cartagena Declaration on Refugees was adopted by the Colloquium on the International Protection of Refugees in Central America, Mexico and Pana...
World's largest Science, Technology & Medicine Open Access book publisher
Chapter 7 from the book People's Movements in the 21st Century - Risks, Challenges and Benefits
Prepared as an outcome of ICMR Subcommittee on Larynx & Hypopharynx Cancers | This consensus document ...n management of larynx and hypopharynx cancers summarizes the modalities of treatment including the site-specific anti-cancer therapies, supportive and palliative care and molecular markers and research questions. It also interweaves clinical, biochemical and epidemiological studies.
Version 1.1. The WHO protocol has been adapted to resource-limited settings and builds on existing methodologies from the European Centre for Disease Prevention and Control (ECDC), the Global PPS project from University ...f Antwerp, the US Centers for Disease Control and Prevention (CDC), and the Medicines Utilisation Research in Africa (MURIA).
Point Prevalence Surveys collects information on prescribing practices of antibiotics and other information relevant to treatment and management of infectious diseases in hospitalized patients, and complements surveillance of antimicrobial consumption.
This Practice Parameter reviews the evidence from research and clinical experience and highlights significant advances in the assessment and treatment of posttraumatic stress disorder since the previous Parameter was published in 1998. It highlights...
The guidelines are aimed at clinical professionals directly involved with and responsible for the care of adults with HIV infection, and at community advocates responsible for promoting the best interests and care ...f HIV-positive adults. They should be read in conjunction with other published BHIVA guidelines.
The 2016 interim update to the 2015 BHIVA antiretroviral guidelines has been published online to include tenofovir-alafenamide/emtricitabine as a preferred NRTI backbone for first-line therapy. Changes were based on new data and the consensus opinion of the writing committee. All changes to the guideline are highlighted and include updates to the chronic kidney disease and bone disease sections of special populations and some small changes to managing virological failure.
The 2019 interim statement provides updated advice on treatment with two-drug regimens
African Evaluation Journal
ISSN: (Online) 2306-5133, (Print) 2310-4988
Background: For some years, non-governmental organisations (NGOs) and civil society have
become increasingly involved in t...
Teachers' Exercise Book for HIV Prevention
Document 6.1
This booklet contains all the participatory learning experiences that are included in the Training and Resource Manual on School Health and HIV and AIDS Prevention. It is to be given to all...
8 July 2020
23 Dec 2020. The aim of this document is to provide an update on the knowledge surrounding the role of children in the transmission ...f SARS-CoV-2 and the role of schools in the COVID-19 pandemic, based on the experience in the EU from August–December, 2020. This document also addresses transmission to and from staff in school settings, school-related mitigation measures including risk communication, testing, contact tracing and the efficacy of partial and full school closures. This document draws upon and updates evidence presented in the previous report from ECDC on this topic, which was published on August 6, 2020
